Jacobs Levy Equity Management, Inc Kala Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$4.93 - $8.8 $61,132 - $109,120	-12,400 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.19 - $8.97 $195,035 - $337,083	-37,579 Reduced 75.19%	12,400 $103,000
Q4 2018 Feb 14, 2019	SELL	$4.29 - $9.94 $135,993 - $315,098	-31,700 Reduced 38.81%	49,979 $244,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $779,217 - $1.13 Million	81,679 New	81,679 $806,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.1M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.